Table 2.
Healthy (n = 17) | Metritis (n = 18) | |||||
---|---|---|---|---|---|---|
Item1 | Ab (n = 9) |
No trt (n = 8) |
SE | Ab (n = 9) |
No trt (n = 9) |
SE |
Fibrosis score | 2.44 | 2.67 | 0.12 | 2.52 | 2.59 | 0.10 |
Epithelial inflammation scorey | 0.87 | 1.15 | 0.10 | 1.21 | 1.00 | 0.08 |
Stromal inflammation scorez | 2.58 | 2.79 | 0.04 | 2.73 | 2.66 | 0.034 |
Eosinophil scorex | 0.94 | 1.33 | 0.17 | 1.76 | 1.40 | 0.14 |
Clear (n = 17) | Purulent (n = 18) | |||||
Item | Ab (n = 10) |
No trt (n = 10) |
SE | Ab (n = 8) |
No trt (n = 7) |
SE |
Fibrosis score** | 2.30 | 2.48 | 0.10 | 2.66 | 2.78 | 0.12 |
Epithelial inflammation score*** | 0.88 | 0.80 | 0.08 | 1.21 | 1.35 | 0.10 |
Stromal inflammation score**,y | 2.65 | 2.62 | 0.03 | 2.66 | 2.84 | 0.04 |
Eosinophil score*** | 1.01 | 0.83 | 0.14 | 1.68 | 1.90 | 0.17 |
Histological scoring of endometrial fibrosis (1 to 3; mild to severe) and endometrial inflammatory cell or eosinophil scored from 0.5 (< 10 cells/field) to 3 (> 50 cells/field)]. Asterix (*P < 0.05, **P < 0.01, ***P < 0.001) is for the probability of the main effect (healthy versus metritis or clear versus purulent). Letter is for the interaction of the main effect with treatment (xP < 0.05, yP<0.01, zP<0.001).